Gabriel Kristian Pedersen (Gabriel K Pedersen)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Venues

NPJ vaccines

Immunological reviews

Advanced healthcare materials

Statens Serum Institut

University of Bergen (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Statens Serum Institut Feb 01 2018

Denmark

Head of Section :: Center for Vaccine Research, Adjuvant research

Statens Serum Institut Mar 01 2016 - Jan 31 2018

Denmark

Postdoc :: Center for Vaccine Research

Karolinska Institutet Oct 01 2012 - Feb 29 2016

Sweden

Postdoc :: Microbiology, Tumor and Cell Biology

Education History

University of Bergen Jan 01 2009 - Mar 13 2012

Norway

PHD :: Influenza Centre

Publications

Julie Zimmermann, Simon Daniel van Haren, Joann Diray-Arce, Ignatius Ryan Adriawan, Katharina Wørzner, Ricki T Krog, Safia Guleed, Tu Hu, Rasmus Mortensen, Jes Dietrich, Sara M Ø Solbak, Ofer Levy, Dennis Christensen, Gabriel Kristian Pedersen
Author Correction: Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells. NPJ vaccines 9 (1) (2024)
Julie Zimmermann, Simon Daniel van Haren, Joann Diray-Arce, Ignatius Ryan Adriawan, Katharina Wørzner, Ricki T Krog, Safia Guleed, Tu Hu, Rasmus Mortensen, Jes Dietrich, Sara M Ø Solbak, Ofer Levy, Dennis Christensen, Gabriel Kristian Pedersen
Author Correction: Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells. NPJ vaccines 9 (1) (2024)
Julie Zimmermann, Simon Daniel van Haren, Joann Arce, Ignatius Ryan Adriawan, Katharina Wørzner, Ricki T Krog, Safia Guleed, Tu Hu, Rasmus Mortensen, Jes Dietrich, Sara M Ø Solbak, Ofer Levy, Dennis Christensen, Gabriel Kristian Pedersen
Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells. NPJ vaccines 8 (1) (2023)
Julie Zimmermann, Simon Daniel van Haren, Joann Diray-Arce, Ignatius Ryan Adriawan, Katharina Wørzner, Ricki T Krog, Safia Guleed, Tu Hu, Rasmus Mortensen, Jes Dietrich, Sara M Ø Solbak, Ofer Levy, Dennis Christensen, Gabriel Kristian Pedersen
Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells. NPJ vaccines 8 (1) (2023)
Julie Zimmermann, Simon Daniel van Haren, Joann Diray-Arce, Ignatius Ryan Adriawan, Katharina Wørzner, Ricki T Krog, Safia Guleed, Tu Hu, Rasmus Mortensen, Jes Dietrich, Sara M Ø Solbak, Ofer Levy, Dennis Christensen, Gabriel Kristian Pedersen
Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells. NPJ vaccines 8 (1) (2023)
Julie Zimmermann, Simon Daniel van Haren, Joann Diray-Arce, Ignatius Ryan Adriawan, Katharina Wørzner, Ricki T Krog, Safia Guleed, Tu Hu, Rasmus Mortensen, Jes Dietrich, Sara M Ø Solbak, Ofer Levy, Dennis Christensen, Gabriel Kristian Pedersen
Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells. NPJ vaccines 8 (1) (2023)
Julie Zimmermann, Simon Daniel van Haren, Joann Diray-Arce, Ignatius Ryan Adriawan, Katharina Wørzner, Ricki T Krog, Safia Guleed, Tu Hu, Rasmus Mortensen, Jes Dietrich, Sara M Ø Solbak, Ofer Levy, Dennis Christensen, Gabriel Kristian Pedersen
Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells. NPJ vaccines 8 (1) (2023)
Julie Zimmermann, Simon Daniel van Haren, Joann Arce, Ignatius Ryan Adriawan, Katharina Wørzner, Ricki T Krog, Safia Guleed, Tu Hu, Rasmus Mortensen, Jes Dietrich, Sara M Ø Solbak, Ofer Levy, Dennis Christensen, Gabriel Kristian Pedersen
Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells. NPJ vaccines 8 (1) (2023)
Lorena Garcia-Del Rio, Patricia Diaz-Rodriguez, Gabriel Kristian Pedersen, Dennis Christensen, Mariana Landín
Sublingual Boosting with a Novel Mucoadhesive Thermogelling Hydrogel Following Parenteral CAF01 Priming as a Strategy Against Chlamydia trachomatis. Advanced healthcare materials 11 (11) (2022)
Virgil Schijns, Alberto Fernández-Tejada, Žarko Barjaktarović, Ilias Bouzalas, Jens Brimnes, Sergey Chernysh, Sveinbjorn Gizurarson, İhsan GÜrsel, Žiga Jakopin, Maria Lawrenz, Cristina Nativi, Stephane Paul, Gabriel Kristian Pedersen, Camillo Rosano, Ane Ruiz-de-Angulo, Bram Slütter, Aneesh Thakur, Dennis Christensen, Ed C Lavelle
Modulation of immune responses using adjuvants to facilitate therapeutic vaccination. Immunological reviews 296 (1) (2020)

Gabriel Kristian Pedersen.css-eqlu8i{font-size:small;padding-left:4px;} (Gabriel K Pedersen)

Publication Activity (10 Years)

Top Topics

Top Venues

Gabriel Kristian Pedersen (Gabriel K Pedersen)